{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:30:53Z","timestamp":1777555853520,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1093\/annonc\/mdm430","type":"journal-article","created":{"date-parts":[[2007,10,16]],"date-time":"2007-10-16T00:59:02Z","timestamp":1192496342000},"page":"115-122","source":"Crossref","is-referenced-by-count":39,"title":["Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group"],"prefix":"10.1016","volume":"19","author":[{"given":"P.A.","family":"Kosmidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.","family":"Kalofonos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Syrigos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Makatsoris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Skarlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bakogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bafaloukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Samantas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Xiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Boukovinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fountzilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm430_bb0010","series-title":"Cancer.: Principles and Practice of Oncology","first-page":"925","article-title":"Non small cell lung cancer","author":"Ginsberg","year":"2001"},{"key":"10.1093\/annonc\/mdm430_bb0015","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials","volume":"311","author":"Non-small Cell Lung Cancer Collaborative Group","year":"1995","journal-title":"BMJ"},{"key":"10.1093\/annonc\/mdm430_bb0020","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1200\/JCO.1999.17.10.3188","article-title":"Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life","volume":"17","author":"Cullen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0025","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO.2002.12.112","article-title":"Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial","volume":"20","author":"Kosmidis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0030","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(00)04644-4","article-title":"Platinum-based and non-platinum-based chemotherapy in advanced non-small cell lung cancer: a randomized multicentre trial","volume":"357","author":"Georgoulias","year":"2001","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdm430_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdm430_bb0040","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1200\/JCO.1989.7.11.1602","article-title":"Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group","volume":"7","author":"Bonomi","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0045","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1200\/JCO.1990.8.9.1556","article-title":"A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer. European Organization for Research and Treatment of Cancer Protocol 07861","volume":"8","author":"Klastersky","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0050","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer","volume":"355","author":"Sandler","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdm430_bb0055","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/1097-0142(20011115)92:10<2639::AID-CNCR1617>3.0.CO;2-8","article-title":"Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E 1594: a phase III trial in patients with metastatic non-small cell lung carcinoma","volume":"92","author":"Sweeney","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm430_bb0060","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1200\/JCO.2005.04.016","article-title":"Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: a phase III randomized trial","volume":"23","author":"Georgoulias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0065","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0070","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d\u2019Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm430_bb0075","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.2005.03.045","article-title":"Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer. A meta-analysis of the published literature","volume":"23","author":"D\u2019 Addario","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419411022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419411022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/1\/115\/434499\/mdm430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T13:16:24Z","timestamp":1582204584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419411022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0923753419411022"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm430","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}